Opinions
Paul Thornton
Mindray Medical International Ltd.
MR-N
PAST TOP PICK
Nov 13, 2009
(A Top Pick Aug 8/08. Down 18%.) Chinese company that makes imaging equipment that got FDA approval about 18 months ago. Earnings growth has tapered off. Now trading in a very flat consolidation and technically it looks like it is going to go higher.
$30.970
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
Pretty diversified but really a play on medical devices and medical testing in China. Layer on the demographics and the need for continued health-care and support for that from the Chinese government. Stocks have been really beaten down but the businesses are still growing. Likes this one for the dynamics.
biotechnology
pharmaceutical
TOP PICK
Advertising